ASPP1/2 have been proposed to promote the activity of the pro-tumour YAP/TAZ transcription co-activators by dephosphorylating an inhibitory residue phosphorylated by the Hippo core kinase cascade35,36. The gene discussed is PPP1R13B; the disease is neoplasm.